Reference
Dhandha MM, et al. Immunophenotype Expression Change from CD52 + to CD52 - On Erythrodermic Peripheral T-cell Lymphoma, Not Otherwise Specified after Treatment with Alemtuzumab. American Journal of Dermatopathology 40: 547-550, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1097/DAD.0000000000001000 - USA
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1742, 19 (2019). https://doi.org/10.1007/s40278-019-58477-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-58477-7